Trial Profile
Recovery of Muscle Function After Deep Neuromuscular Block by Means of Dia-phragm Ultrasonography and Adductor Pollicis Acceleromyography: Comparison of Neostigmine vs. Sugammadex as Reversal Drugs.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Fentanyl; Neostigmine; Propofol; Rocuronium bromide; Sevoflurane
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 24 Oct 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Feb 2017.
- 09 Mar 2016 New trial record